Skip to main content
Fig. 2 | Human Genomics

Fig. 2

From: 2-deoxy-2-[18]fluoro-D-glucose PET/CT (18FDG PET/CT) may not be a viable biomarker in Pompe disease

Fig. 2

MR scans of a Pompe patient at the level just below the pelvic floor. There are different stages of muscular inflammation, or atrophy respectively, visible: T1w images show fatty atrophy in various muscles, pronounced in the middle part of the gluteus maximus (a, arrow head). The medial part of the gluteus maximus shows only beginning atrophy at T1w (a, arrow) together with high signal in the STIR images (b). T1w FS scans also display high signal after gadolinium administration (c). While the tensor fasciae latae muscle (wide arrow) seems to be unaffected in the T1w images, there is high signal on STIR and T1w FS scans suggesting early changes

Back to article page